Jeongha Lee

Jeongha Lee

Auto-generated profile, based on publicly available information

Jeongha Lee

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Molecules and Cells
Verified
Journal Article
Open access
SHSung Eun Hong
Sung Eun Hong
MCMurim Choi
Murim Choi
JLJeongha Lee
Jeongha Lee
Attaining a complete understanding of the genetic architecture underlying common complex traits is challenging due to the substantial contributions of nongenetic factors and the involvement of numerous influencing genes. Genome-wide association studies (GWAS) have identified novel variants associated with such traits, but our understanding of the molecular genetic mechanisms underlying those associations remains limited. Additionally, variants without significant associations from GWAS can influence gene expression, contributing to individual-level variation in traits. This review summarizes the evolution, advancements in, and practical applications of expression quantitative trait loci analysis. Recent large-scale expression quantitative trait loci studies, often at the single-cell level, provide an opportunity to explain how at least some GWAS variants behave and to elucidate the mechanisms underlying individual-level variations. This approach can further be utilized to identify novel drug targets that are tailored to individuals harboring specific genotypes.

8 November 2024 in Circulation Research
Verified
Journal Article
Closed access
MKMinjun Kang
Minjun Kang
CLChoon-Soo Lee
Choon-Soo Lee
HSHyunJu Son
HyunJu Son
JLJeongha Lee
Jeongha Lee
JLJaewon Lee
Jaewon Lee
HKHyoSoo Kim
HyoSoo Kim
BACKGROUND: Latrophilin-2 (Lphn2), an adhesive GPCR (G protein-coupled receptor), was found to be a specific marker of cardiac progenitors during the differentiation of pluripotent stem cells into cardiomyocytes or during embryonic heart development in our previous studies. Its role in adult heart physiology, however, remains unclear. METHODS: The embryonic lethality resulting from Lphn2 deletion necessitates the establishment of cardiomyocyte-specific, tamoxifen-inducible Lphn2 knockout mice, which was achieved by crossing Lphn2  flox/flox mice with mice having MerCreMer (tamoxifen-inducible Cre [Cyclization recombinase] recombinase) under the α-myosin heavy chain promoter. RESULTS: Tamoxifen treatment for several days completely suppressed Lphn2 expression, specifically in the myocardium, and induced the dilated cardiomyopathy (D-CMP) phenotype with serious arrhythmia and sudden death in a short period of time. Transmission electron microscopy showed mitochondrial abnormalities, blurred Z-discs, and dehiscent myofibrils. The D-CMP phenotype, or heart failure, worsened during myocardial infarction. In a mechanistic study of D-CMP, Lphn2 knockout suppressed PGC-1α (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha) and mitochondrial dysfunction, leading to the accumulation of reactive oxygen species and the global suppression of junctional molecules, such as N-cadherin (adherens junction), DSC-2 (desmocollin-2; desmosome), and connexin-43 (gap junction), leading to the dehiscence of cardiac myofibers and serious arrhythmia. In an experimental therapeutic trial, activators of p38-MAPK (p38 mitogen-activated protein kinases), which is a downstream signaling molecule of Lphn2, remarkably rescued the D-CMP phenotype of Lphn2 knockout in the heart by restoring PGC-1α and mitochondrial function and recovering global junctional proteins. CONCLUSIONS: Lphn2 is a critical regulator of heart integrity by controlling mitochondrial functions and cell-to-cell junctions in cardiomyocytes. Its deficiency leads to D-CMP, which can be rescued by activators of the p38-MAPK pathway.

30 March 2026 in Advanced Science
Verified
Journal Article
Open access
PDF file
YKYe Seul Kim
Ye Seul Kim
JJJeonghwa Jeong
Jeonghwa Jeong
GHGyeonghwa Heo
Gyeonghwa Heo
YKYoung Woo Kwon
Young Woo Kwon
JLJeongha Lee
Jeongha Lee
JKJae Ho Kim
Jae Ho Kim
We present an integrated microelectrode array (MEA) platform for high‐precision electrophysiological characterization of patient‐derived 3D cardiac organoids (COs), enabling dynamic recordings from both healthy and Duchenne muscular dystrophy (DMD) “mini‐hearts.” A deformable MEA, fabricated by photolithographic patterning of support layers and microelectrodes, is conformally assembled onto a customized scoop‐slide well. The concave geometry enables passive self‐alignment of millimeter‐scale COs within a multichannel electrode array, allowing simultaneous extracellular field potential (EFP) recording and video‐based motion analysis. Using COs derived from human induced pluripotent stem cells of healthy donors and a DMD patient, we resolved region‐specific EFP waveforms, which were validated by calcium imaging. DMD COs exhibited severe arrhythmic firing and aberrant waveform morphologies, in contrast to the stable, isochronal rhythms of healthy controls. Single‐cell transcriptomic analysis revealed a pathological DMD signature marked by excessive extracellular matrix accumulation and disorganized cardiac architecture, contributing to conduction heterogeneity. Pharmacological challenge with the hERG blocker E‐4031 prolonged field potential duration in normal COs but triggered disorganized arrhythmogenic storms in DMD COs. By overcoming the limitations of rigid interfaces and ensuring structural preservation with stable impedance coupling, the presented platform provides a robust biointerface for disease phenotyping, drug screening, and mechanistic interrogation of 3D cardiac tissues.

24 August 2025 in bioRxiv
Verified
Preprint
Open access
SPSeong Kyoon Park
Seong Kyoon Park
JLJeongha Lee
Jeongha Lee
SPSeon Ju Park
Seon Ju Park
YKYe Na Kim
Ye Na Kim
GSGi Hyun Shin
Gi Hyun Shin
MCMurim Choi
Murim Choi
Numerous proteins display pleiotropic functions in different clinical contexts. However, molecular mechanism underlying such effects is rarely understood. Speckle-type POZ protein ( SPOP ) is a typical example, exhibiting tumor-suppressing or -promoting effects in different tumor types in accordance with different amino acid changes; specifically, two distinct sets of variants in SPOP are commonly found in subsets of prostate cancer and endometrial cancer patients. To comprehensively characterize the functional landscape of SPOP alteration, we performed a deep mutational screening (DMS), elucidating the functionality of 7,933 out of 8,228 possible single amino acid changes (96.4% coverage). Leveraging the observation that overexpression of human SPOP leads to yeast growth arrest, we assessed the functionality of each variant using a yeast proliferation assay. In addition, our approach combined long-read and short-read sequencing. Finally, our DMS model enables a clear distinction of likely-loss-of-function (LoF) variants that are enriched in prostate cancers and reveals their differential characteristics in both protein structure and genetic assessments. These results demonstrate the utility of our approach in high resolution mapping and amino-acid-level interpretation of protein function. Significance statement: Genetic mutations often play different roles in cancer, driving or suppressing tumor growth depending on their molecular context. The protein SPOP is a striking example that acts as either a tumor-suppressor or oncogene depending on the specific mutation and tissue. However, understanding how thousands of possible mutations alter its function has been a major challenge. Here, we applied deep mutational scanning to experimentally measure the functional effects of nearly every possible amino acid change in SPOP . This work provides the first comprehensive functional map of SPOP variants, not only advancing basic knowledge of cancer biology but also establishing a framework for interpreting patient mutations in precision medicine.

6 May 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SPSeong Kyun Park
Seong Kyun Park
JLJeongha Lee
Jeongha Lee
SPSeon Ju Park
Seon Ju Park
YKYe Na Kim
Ye Na Kim
GSGi Hyun Shin
Gi Hyun Shin
MCMurim Choi
Murim Choi
Numerous proteins display pleiotropic functions in different clinical contexts. However, the molecular mechanism underlying such effects is rarely understood. Speckle-type POZ protein ( SPOP ) is a typical example, exhibiting tumor-suppressing or tumor-promoting effects in different tumor types in accordance with different amino acid changes; specifically, two distinct sets of variants in SPOP are commonly found in subsets of prostate cancer and endometrial cancer patients. To comprehensively characterize the functional landscape of SPOP alteration, we performed a deep mutational screening (DMS), elucidating the functionality of 7,933 out of 8,228 possible single amino acid changes (96.4% coverage). Leveraging the observation that overexpression of human SPOP leads to yeast growth arrest, we assessed the functionality of each variant using a yeast proliferation assay. In addition, our approach combined long-read and short-read sequencing. Finally, our DMS model enables a clear distinction of likely-loss-of-function variants that are enriched in prostate cancers and reveals their differential characteristics in both protein structure and genetic assessments. These results demonstrate the utility of our approach in high-resolution mapping and amino acid–level interpretation of protein function.